Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HPGD | P15428 | 16/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.44 |
| ▸ | PARP1 | P09874 | 1/20 | 0.41 |
| ▸ | PIM1 | P11309 | 1/20 | 0.39 |
| ▸ | PIM2 | Q9P1W9 | 1/20 | 0.39 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17289311 | 1.00 | HPGD (0.44) | HPGDMEN1MAPTKMT2ATDP1 | |
| SCHEMBL6974812 | 1.00 | HPGD (0.44) | HPGDMEN1MAPTKMT2ATDP1 | |
| SCHEMBL6970058 | 1.00 | HPGD (0.44) | HPGDMEN1MAPTKMT2ATDP1 | |
| SCHEMBL6975305 | 0.87 | HPGD (0.47) | HPGDMEN1KMT2A | |
| SCHEMBL6970447 | 0.87 | HPGD (0.47) | HPGDMEN1KMT2A | |
| SCHEMBL6975793 | 0.87 | HPGD (0.47) | HPGDMEN1KMT2A | |
| SCHEMBL6975790 | 0.87 | HPGD (0.47) | HPGDMEN1KMT2A | |
| SCHEMBL6962895 | 0.83 | MAPT (0.47) | HPGDMEN1MAPTKMT2ATDP1 | |
| SCHEMBL6966713 | 0.83 | MAPT (0.47) | HPGDMEN1MAPTKMT2ATDP1 | |
| SCHEMBL6969023 | 0.83 | MAPT (0.47) | HPGDMEN1MAPTKMT2ATDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210227822-A1 | COMPOUNDS FOR PROTECTION OF CELLS | SULFATEQ B.V. (NL) | 2021-07-29 | — | — | US | disclosed |
| US-11006626-B2 | Compounds for protection of cells | SULFATEQ B.V. (NL) | 2021-05-18 | — | — | US | disclosed |
| US-20190098890-A1 | COMPOUNDS FOR PROTECTION OF CELLS | SULFATEQ B.V. (NL) | 2019-04-04 | — | — | US | disclosed |
| US-10123529-B2 | Compounds for protection of cells | SULFATEQ B.V. (NL) | 2018-11-13 | — | — | US | disclosed |
| EP-3388426-A2 | COMPOUNDS FOR PROTECTION OF CELLS | Sulfateq B.V. (NL) | 2018-10-17 | — | — | EP | disclosed |
| EP-2935232-B1 | COMPOUNDS FOR PROTECTION OF CELLS | SULFATEQ BV (NL) | 2018-06-13 | — | — | EP | disclosed |
| US-20150342174-A1 | COMPOUNDS FOR PROTECTION OF CELLS | SULFATEQ B.V. (NL) | 2015-12-03 | — | — | US | disclosed |
| EP-0894089-B9 | NOVEL HETEROCYCLIC COMPOUNDS HAVING ANTIDIABETIC, HYPOLIPIDAEMIC, ANTIHYPERTENSIVE PROPERTIES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | REDDYS LAB LTD DR (IN) | 2003-04-02 | — | — | EP | disclosed |
| EP-0894089-B1 | NOVEL HETEROCYCLIC COMPOUNDS HAVING ANTIDIABETIC, HYPOLIPIDAEMIC, ANTIHYPERTENSIVE PROPERTIES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | REDDYS LAB LTD DR (IN) | 2002-10-23 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11006626-B2 | Compounds for protection of cells | CASP10, BAX, CASP9 | HPGD 1301/4885MEN1 1227/4885MAPT 4696/4885 |
| US-20190098890-A1 | COMPOUNDS FOR PROTECTION OF CELLS | CASP10, BAX, CASP9 | HPGD 1301/4885MEN1 1227/4885MAPT 4696/4885 |
| US-20210227822-A1 | COMPOUNDS FOR PROTECTION OF CELLS | CASP10, BAX, CASP9 | HPGD 1301/4885MEN1 1227/4885MAPT 4696/4885 |
| US-10123529-B2 | Compounds for protection of cells | CASP10, BAX, CASP9 | HPGD 1301/4885MEN1 1227/4885MAPT 4696/4885 |
| US-20150342174-A1 | COMPOUNDS FOR PROTECTION OF CELLS | CASP10, BAX, CASP9 | HPGD 1301/4885MEN1 1227/4885MAPT 4696/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.